Find uplifting stories about heroes, innovations, and solutions
144 results for "nhs"
A new NHS pilot uses AI and robotic catheters to diagnose lung cancer in a single appointment instead of weeks of anxious waiting. The technology has already helped 215 patients start cancer treatment faster.
A groundbreaking NHS study using data from 29 million people reveals how secure health monitoring can spot disease trends early and help fix care gaps. The research shows chronic kidney disease diagnoses jumped 35% above expected levels, likely due to better testing and new treatments.
The NHS is creating the world's first national database of 120 cancer-linked genes, offering free genetic testing and early screening to tens of thousands of families. It's a game-changing shift from treating cancer to preventing it before it starts.
Hundreds of women with hard-to-treat ovarian cancer will now receive a groundbreaking new therapy that extends life while dramatically reducing the debilitating side effects of traditional chemotherapy. The approval marks the first new ovarian cancer treatment on the NHS in two decades.
UK cancer patients can now receive three chemotherapy cycles instead of six without compromising survival, following groundbreaking research that prioritizes quality of life. The NHS has already updated its treatment guidelines to offer this less toxic option.
A new NHS campaign is rallying blood donors to help fill a critical shortage affecting thousands of sickle cell patients across England. Major brands are draining the red from their logos to spotlight the urgent need.
A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years. About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.
A groundbreaking treatment can now delay type 1 diabetes for up to three years, giving families precious time before symptoms begin. The NHS has approved the first-ever drug that stops the disease in its tracks during early stages.
Patients in England with advanced gastrointestinal stromal tumors now have a fourth treatment option after NHS approved ripretinib, a drug that extends life with fewer side effects. For those who've exhausted all other therapies and faced weeks to live, this approval brings genuine hope.
A team of volunteer drivers in Shropshire is transforming patient care while saving the NHS thousands. Their simple act of driving patients home could save £30 million if rolled out nationwide.
Around 20 people in England with a debilitating genetic condition can now access the first treatment that targets the root cause of their disease. The NHS will provide pegzilarginase to patients with arginase-1 deficiency after breakthrough approval.
A new one-minute cancer treatment is replacing two-hour hospital sessions for 14,000 patients across England. The breakthrough immunotherapy injection frees patients to live their lives while helping the NHS treat more people faster.
A father who lost his dad to Motor Neurone Disease is fighting to make a treatment that slows the condition available to NHS patients. The drug Tofersen costs just £8,000 per patient and has shown remarkable results for people with a specific gene variation.
Boys living with Duchenne muscular dystrophy in England now have access to a new treatment that could extend their ability to walk by up to five years. The NHS has approved givinostat, offering fresh hope to families facing this devastating muscle-wasting disease.
A breakthrough cream that targets the root cause of vitiligo will now be available free through England's NHS, offering hope to people living with the skin condition. The treatment has shown remarkable results in restoring skin pigmentation for thousands who previously had limited options.
After two decades, women with hard-to-treat ovarian cancer finally have a new option. The targeted therapy offers more precious time with loved ones and dramatically fewer side effects than traditional chemotherapy.
Dr. Inna Soldatenko fled Kharkiv with her family when war broke out, arriving in the UK with little more than hope. Three years later, she's practicing medicine again and helping dozens of refugee healthcare workers do the same.
Women in England who can't take hormone replacement therapy now have access to a groundbreaking pill that dramatically reduces hot flushes and night sweats. The move brings relief to half a million women whose options were previously limited.
After two decades without a breakthrough, England's health service has approved a targeted therapy that offers new hope to women with hard-to-treat ovarian cancer. Around 400 patients annually will now access this "biological missile" treatment that doubles as their first option when chemotherapy stops working.
Children across England and Wales can now access teplizumab, the groundbreaking drug that delays type 1 diabetes symptoms by three years. After decades of research, this immunotherapy treatment gives families precious extra time before daily insulin management begins.
Showing 20 of 144